This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2024. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.
| Item | Value |
|---|---|
| Country | |
| Facebook page | nih.gov |
| Website | https://www.nih.gov |
| Twitter username | NIH |
| Wikipedia page | https://en.wikipedia.org/wiki/National_Institutes_of_Health |
| Cause area | Count | Median | Mean | Minimum | 10th percentile | 20th percentile | 30th percentile | 40th percentile | 50th percentile | 60th percentile | 70th percentile | 80th percentile | 90th percentile | Maximum |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall | 10 | 101,000 | 178,734 | -168,410 | 0 | 0 | 100,000 | 100,000 | 101,000 | 166,995 | 209,048 | 353,295 | 479,911 | 529,003 |
| Global health | 8 | 101,000 | 212,981 | -168,410 | 0 | 100,000 | 100,000 | 101,000 | 101,000 | 209,048 | 353,295 | 479,911 | 529,003 | 529,003 |
| Nutrition | 2 | -83,498 | 41,749 | -83,498 | 0 | 0 | 0 | 0 | 0 | 166,995 | 166,995 | 166,995 | 166,995 | 166,995 |
| Donor | Total | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation (filter this donee) | 1,787,344.50 | -168,410.00 | -83,497.50 | 833,206.00 | 166,995.00 | 209,048.00 | 630,003.00 | 100,000.00 | 100,000.00 |
| Total | 1,787,344.50 | -168,410.00 | -83,497.50 | 833,206.00 | 166,995.00 | 209,048.00 | 630,003.00 | 100,000.00 | 100,000.00 |
There are no documents associated with this donee.
Graph of top 10 donors (for donations with known year of donation) by amount, showing the timeframe of donations
| Donor | Amount (current USD) | Amount rank (out of 10) | Donation date | Cause area | URL | Influencer | Notes |
|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation | -168,410.00 | 10 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop and distribute a high-titered anti-Vi IgG reference serum to facilitate the development of novel efficacious capsular polysaccharide Vi-typhoid conjugate vaccine candidates that may be administered during infancy. This reference serum may obvi; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -83,497.50 | 9 | Nutrition/basic nutrition | https://iatiregistry.org/publisher/bmgf | -- | To provide data analytics and modeling support to identify what intervention packages are the most cost effective for improving healthy growth for what population groups at what stage in the lifecycle.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 353,295.00 | 3 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | To better understand if clearance of malaria will improve T cell function and improve immune responses to vaccines; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 479,911.00 | 2 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to test whether “unnatural immunity” (antibodies that are not generated in natural infection) against structures that form a capsule uniquely on the surface of infecting promastigotes, can prevent infection in the mammalian host, as well block the develop; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 166,995.00 | 5 | Nutrition/basic nutrition | https://iatiregistry.org/publisher/bmgf | -- | To provide data analytics and modeling support to identify what intervention packages are the most cost effective for improving healthy growth for what population groups at what stage in the lifecycle.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 209,048.00 | 4 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to test whether “unnatural immunity” (antibodies that are not generated in natural infection) against structures that form a capsule uniquely on the surface of infecting promastigotes, can prevent infection in the mammalian host, as well block the develop; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 101,000.00 | 6 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to test whether “unnatural immunity” (antibodies that are not generated in natural infection) against structures that form a capsule uniquely on the surface of infecting promastigotes, can prevent infection in the mammalian host, as well block the develop; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 529,003.00 | 1 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop and distribute a high-titered anti-Vi IgG reference serum to facilitate the development of novel efficacious capsular polysaccharide Vi-typhoid conjugate vaccine candidates that may be administered during infancy. This reference serum may obvi; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 7 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop a novel vaccine against salivary proteins of sand fl ies with the aim to induce a strong immune response against the parasite; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 7 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to use a viral genome as a model to study superinfection restriction. Viral genome as a model to study superinfection restriction. Investment start date: 5/1/2009 to end date: 10/31/2010. Grantee name: National Institutes of Health; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. |